As more research emerges, GLP-1 medications may become a powerful adjunct therapy in rheumatologysupporting traditional treatments and improving long-term outcomes
Gradual Transition: Stopping If you choose to stop, you must work with a health professional
OME service Packaging & Shipping Certification How To Contact Us
Last year, a team of researchers at the Case Western Reserve University School of Medicine studied 1.6 million patients with type 2 diabetes and found that those on GLP-1 drugs had significant risk reduction of ten cancers: esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer, as well as meningioma and multiple myeloma
Some telehealth companies like Ro and Hims hire third-party companies to test the compounded medications for quality and purity, but not all of them do
Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US